Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Aprogenex Inc.

Latest From Aprogenex Inc.

Kissei broadens biosimilar ambitions through Alteogen alliance

The mid-sized Japanese pharmaceutical firm Kissei is expanding its interests in biosimilars through a new collaboration with the South Korean venture Alteogen.


Nichi-Iko rights offering to support production, biosimilar plans

The major Japanese generics firm Nichi-Iko Pharmaceutical is planning to raise an estimated JPY12.58bn ($123m) in total net proceeds from a new rights offering, with the new funds already earmarked for an array of capital investment and product development projects.


Nichi-Iko widens Asian push with Vietnam alliance

Nichi-Iko Pharmaceutical is continuing its strategic expansion into Southeast Asian markets through a new alliance with Vietnam's Hanoi Pharmaceutical.


Nichi-Iko buys into Korean biosimilar capacity

Nichi-Iko Pharmaceutical, one of Japan's largest generics firms, has acquired a 12.6% equity stake in Binex, a South Korean contract manufacturer, in an alliance it says will focus on the production of biosimilars.

Cancer Japan
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics